[ { "key": "DTBH2KBA", "version": 49, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/DTBH2KBA", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/DTBH2KBA", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/C5VP35TW", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "DTBH2KBA", "version": 49, "parentItem": "C5VP35TW", "itemType": "attachment", "linkMode": "imported_url", "title": "Kite Pharma Announces Proposed Public Offering of Common Stock (NASDAQ:KITE)", "accessDate": "2015-12-16T11:39:15Z", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=946150", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releasedetail.html", "md5": "1d6c09c62c68f6de35f97e437aa71071", "mtime": 1450265954142, "tags": [], "relations": {}, "dateAdded": "2015-12-16T11:39:15Z", "dateModified": "2015-12-16T11:39:15Z" } }, { "key": "C5VP35TW", "version": 48, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/C5VP35TW", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/C5VP35TW", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "C5VP35TW", "version": 48, "itemType": "webpage", "title": "Kite Pharma Announces Proposed Public Offering of Common Stock (NASDAQ:KITE)", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=946150", "accessDate": "2015-12-16T11:39:14Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T11:39:14Z", "dateModified": "2015-12-16T11:39:14Z" } }, { "key": "FP2PNZVE", "version": 47, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/FP2PNZVE", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/FP2PNZVE", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/Q8P4SB7Q", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "FP2PNZVE", "version": 47, "parentItem": "Q8P4SB7Q", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-12-16T11:13:54Z", "url": "http://ir.junotherapeutics.com/phoenix.zhtml?c=253828&p=irol-newsArticle&ID=1999939", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "phoenix.html", "md5": "f4dc527fafc4bc024bf937346c6cf976", "mtime": 1450264435339, "tags": [], "relations": {}, "dateAdded": "2015-12-16T11:13:54Z", "dateModified": "2015-12-16T11:13:54Z" } }, { "key": "VHN4NPTZ", "version": 44, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/VHN4NPTZ", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/VHN4NPTZ", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/JVIZQRZ3", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "VHN4NPTZ", "version": 44, "parentItem": "JVIZQRZ3", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-12-16T11:13:06Z", "url": "http://ir.junotherapeutics.com/phoenix.zhtml?c=253828&p=irol-newsArticle&ID=1999945", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "phoenix.html", "md5": "ff7c46954283ff9f9c66ac65782f4c68", "mtime": 1450264387112, "tags": [], "relations": {}, "dateAdded": "2015-12-16T11:13:06Z", "dateModified": "2015-12-16T11:13:06Z" } }, { "key": "JVIZQRZ3", "version": 43, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/JVIZQRZ3", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/JVIZQRZ3", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "JVIZQRZ3", "version": 43, "itemType": "blogPost", "title": "Investor Relations", "creators": [], "abstractNote": "> Investor Relations", "blogTitle": "Juno Therapeutics", "websiteType": "", "date": "", "DOI": "", "citationKey": "", "url": "http://ir.junotherapeutics.com/", "accessDate": "2015-12-16T11:13:03Z", "ISSN": "", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T11:13:03Z", "dateModified": "2015-12-16T11:13:03Z" } }, { "key": "4JP5NJ5Z", "version": 42, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/4JP5NJ5Z", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/4JP5NJ5Z", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/9GCJ2GZV", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "4JP5NJ5Z", "version": 42, "parentItem": "9GCJ2GZV", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-12-16T10:36:48Z", "url": "http://www.fiercebiotech.com/story/novartiss-leading-car-t-cancer-therapy-gains-breakthrough-status-fda/2014-07-07", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "2014-07-07.html", "md5": "a2fad928f2ae443ef53a89bc2aae915a", "mtime": 1450262209295, "tags": [], "relations": {}, "dateAdded": "2015-12-16T10:36:48Z", "dateModified": "2015-12-16T10:36:48Z" } }, { "key": "9GCJ2GZV", "version": 41, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/9GCJ2GZV", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/9GCJ2GZV", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "creatorSummary": "Carroll", "numChildren": 1 }, "data": { "key": "9GCJ2GZV", "version": 41, "itemType": "webpage", "title": "Novartis' leading CAR-T cancer therapy gains breakthrough status at the FDA", "creators": [ { "creatorType": "author", "firstName": "John", "lastName": "Carroll" } ], "abstractNote": "The FDA has provided its special 'breakthrough' status for Novartis' closely-watched development program for a personalized CAR-T cancer therapy, promising to help speed development for engineered T cells.", "websiteTitle": "FierceBiotech", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://www.fiercebiotech.com/story/novartiss-leading-car-t-cancer-therapy-gains-breakthrough-status-fda/2014-07-07", "accessDate": "2015-12-16T10:36:44Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T10:36:44Z", "dateModified": "2015-12-16T10:36:44Z" } }, { "key": "9XPU9FQ9", "version": 42, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/9XPU9FQ9", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/9XPU9FQ9", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/CQB9K66J", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "9XPU9FQ9", "version": 42, "parentItem": "CQB9K66J", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-12-16T10:36:42Z", "url": "http://finance.yahoo.com/news/juno-investigational-car-t-cell-131700101.html;_ylt=AwrTccU2O3FWSyEAIBgnnIlQ;_ylu=X3oDMTByMjR0MTVzBGNvbG8DZ3ExBHBvcwM3BHZ0aWQDBHNlYwNzcg--", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "juno-investigational-car-t-cell-131700101.html", "md5": "d23dcefe3bd1427bb27f11b7480a3731", "mtime": 1450262203602, "tags": [], "relations": {}, "dateAdded": "2015-12-16T10:36:42Z", "dateModified": "2015-12-16T10:36:42Z" } }, { "key": "CQB9K66J", "version": 41, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/CQB9K66J", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/CQB9K66J", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "CQB9K66J", "version": 41, "itemType": "webpage", "title": "Juno’s Investigational CAR T Cell Product Candidates JCAR014 and JCAR018 Demonstrate Encouraging Clinical Responses in Patients with B-Cell Cancers", "creators": [], "abstractNote": "Juno Therapeutics, Inc. , a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced, in partnership with its collaborators, that clinical data from a chimeric antigen receptor T cell product candidate, JCAR014, demonstrated encouraging clinical responses in patients with relapsed or refractory non-Hodgkin lymphoma and chronic ...", "websiteTitle": "Yahoo Finance", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://finance.yahoo.com/news/juno-investigational-car-t-cell-131700101.html", "accessDate": "2015-12-16T10:36:40Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T10:36:40Z", "dateModified": "2015-12-16T10:36:40Z" } }, { "key": "MDN389KB", "version": 40, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/MDN389KB", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/MDN389KB", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/TES8KE5W", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "MDN389KB", "version": 40, "parentItem": "TES8KE5W", "itemType": "attachment", "linkMode": "imported_url", "title": "Healthcare – Google Finance", "accessDate": "2015-12-16T10:35:30Z", "url": "https://www.google.co.uk/finance?catid=us-TRBC%3A56&sort=MARKET_CAP&ei=be2fVYHtL4ybsgHyt4nACg", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "finance.html", "md5": "f0d4b2e9fdd3accb308cc52c18d277ff", "mtime": 1450262130368, "tags": [], "relations": {}, "dateAdded": "2015-12-16T10:35:30Z", "dateModified": "2015-12-16T10:35:30Z" } }, { "key": "TES8KE5W", "version": 39, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/TES8KE5W", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/TES8KE5W", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "TES8KE5W", "version": 39, "itemType": "webpage", "title": "Healthcare – Google Finance", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "https://www.google.co.uk/finance?catid=us-TRBC%3A56&sort=MARKET_CAP&ei=be2fVYHtL4ybsgHyt4nACg", "accessDate": "2015-12-16T10:35:29Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T10:35:29Z", "dateModified": "2015-12-16T10:35:29Z" } }, { "key": "HZUM3NSA", "version": 38, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/HZUM3NSA", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/HZUM3NSA", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "HZUM3NSA", "version": 38, "itemType": "webpage", "title": "Kite Pharma 10-Q", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://www.sec.gov/Archives/edgar/data/1510580/000156459015010571/kite-10q_20150930.htm", "accessDate": "2015-12-16T10:28:37Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T10:28:37Z", "dateModified": "2015-12-16T10:29:16Z" } }, { "key": "6KK5ECEP", "version": 37, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/6KK5ECEP", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/6KK5ECEP", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/HZUM3NSA", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "6KK5ECEP", "version": 37, "parentItem": "HZUM3NSA", "itemType": "attachment", "linkMode": "imported_url", "title": "kite-10q_20150930.htm", "accessDate": "2015-12-16T10:28:38Z", "url": "http://www.sec.gov/Archives/edgar/data/1510580/000156459015010571/kite-10q_20150930.htm", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "kite-10q_20150930.html", "md5": "1bc869955e522e85d73673e4dd7b5105", "mtime": 1450261719738, "tags": [], "relations": {}, "dateAdded": "2015-12-16T10:28:38Z", "dateModified": "2015-12-16T10:28:38Z" } }, { "key": "UCZM4RIS", "version": 35, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/UCZM4RIS", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/UCZM4RIS", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/D83VNWVF", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "UCZM4RIS", "version": 35, "parentItem": "D83VNWVF", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-12-16T10:24:33Z", "url": "http://finance.yahoo.com/news/juno-investigational-car-t-cell-131700101.html;_ylt=AwrTccU2O3FWSyEAIBgnnIlQ;_ylu=X3oDMTByMjR0MTVzBGNvbG8DZ3ExBHBvcwM3BHZ0aWQDBHNlYwNzcg--", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "juno-investigational-car-t-cell-131700101.html", "md5": "1dcfeb3e48c0a646a0b9257d19db9327", "mtime": 1450261474850, "tags": [], "relations": {}, "dateAdded": "2015-12-16T10:24:33Z", "dateModified": "2015-12-16T10:24:33Z" } }, { "key": "VV4GXK8H", "version": 33, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/VV4GXK8H", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/VV4GXK8H", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/5ZH3P7VZ", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "VV4GXK8H", "version": 33, "parentItem": "5ZH3P7VZ", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-12-16T09:53:55Z", "url": "https://www.linkedin.com/company/kite-pharma-inc-", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "kite-pharma-inc-.html", "md5": "6cb01b013e2263285720d941731d5525", "mtime": 1450259636637, "tags": [], "relations": {}, "dateAdded": "2015-12-16T09:53:55Z", "dateModified": "2015-12-16T09:53:55Z" } }, { "key": "5ZH3P7VZ", "version": 32, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/5ZH3P7VZ", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/5ZH3P7VZ", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "creatorSummary": "Monica and States", "numChildren": 1 }, "data": { "key": "5ZH3P7VZ", "version": 32, "itemType": "webpage", "title": "Kite Pharma, Inc.", "creators": [ { "creatorType": "author", "firstName": "Headquarters 2225 Colorado Ave Santa", "lastName": "Monica" }, { "creatorType": "author", "firstName": "California 90404 United", "lastName": "States" } ], "abstractNote": "Kite Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to selectively target and kill cancer cells. Our core technology involves the genetic engineering of T cells, or white blood cells, to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs) for the treatment of advanced solid and hematological malignancies. We are on a rapid growth trajectory and have a highly energized and accomplished team. Kite is publicly traded (NASDAQ: KITE) with a current market well over $2 Billion.", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "https://www.linkedin.com/company/kite-pharma-inc-", "accessDate": "2015-12-16T09:53:54Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T09:53:54Z", "dateModified": "2015-12-16T09:53:54Z" } }, { "key": "DGN5954F", "version": 31, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/DGN5954F", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/DGN5954F", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/JUJWFVIA", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "DGN5954F", "version": 31, "parentItem": "JUJWFVIA", "itemType": "attachment", "linkMode": "imported_url", "title": "Kite Pharma Names David Chang, M.D., Ph.D., to Lead R&D Programs (NASDAQ:KITE)", "accessDate": "2015-12-16T09:31:10Z", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852486", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releasedetail.html", "md5": "9196eae8b70ff21e68b6c88bad50a361", "mtime": 1450258269147, "tags": [], "relations": {}, "dateAdded": "2015-12-16T09:31:10Z", "dateModified": "2015-12-16T09:31:10Z" } }, { "key": "JUJWFVIA", "version": 30, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/JUJWFVIA", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/JUJWFVIA", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "JUJWFVIA", "version": 30, "itemType": "webpage", "title": "Kite Pharma Names David Chang, M.D., Ph.D., to Lead R&D Programs (NASDAQ:KITE)", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852486", "accessDate": "2015-12-16T09:31:09Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T09:31:09Z", "dateModified": "2015-12-16T09:31:09Z" } }, { "key": "3IDCQT37", "version": 29, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/3IDCQT37", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/3IDCQT37", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/S38FWM7V", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "3IDCQT37", "version": 29, "parentItem": "S38FWM7V", "itemType": "attachment", "linkMode": "imported_url", "title": "Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer (NASDAQ:KITE)", "accessDate": "2015-12-16T09:28:58Z", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852504", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releasedetail.html", "md5": "d72c9a6e8f0c0913a90060b20aa199fe", "mtime": 1450258137980, "tags": [], "relations": {}, "dateAdded": "2015-12-16T09:28:58Z", "dateModified": "2015-12-16T09:28:58Z" } }, { "key": "S38FWM7V", "version": 28, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/S38FWM7V", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/S38FWM7V", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "S38FWM7V", "version": 28, "itemType": "webpage", "title": "Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer (NASDAQ:KITE)", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852504", "accessDate": "2015-12-16T09:28:57Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T09:28:57Z", "dateModified": "2015-12-16T09:28:57Z" } }, { "key": "NWBIKEPW", "version": 27, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/NWBIKEPW", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/NWBIKEPW", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/EFUFNUJC", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "NWBIKEPW", "version": 27, "parentItem": "EFUFNUJC", "itemType": "attachment", "linkMode": "imported_url", "title": "Kite Pharma Announces the Appointment of Arie Belldegrun, M.D., as President and Chief Executive Officer (NASDAQ:KITE)", "accessDate": "2015-12-16T08:46:53Z", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852494", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releasedetail.html", "md5": "678f4ac2d1b0e79fffc08b34754b62ba", "mtime": 1450255614384, "tags": [], "relations": {}, "dateAdded": "2015-12-16T08:46:53Z", "dateModified": "2015-12-16T08:46:53Z" } }, { "key": "EFUFNUJC", "version": 26, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/EFUFNUJC", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/EFUFNUJC", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "EFUFNUJC", "version": 26, "itemType": "webpage", "title": "Kite Pharma Announces the Appointment of Arie Belldegrun, M.D., as President and Chief Executive Officer (NASDAQ:KITE)", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852494", "accessDate": "2015-12-16T08:46:51Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T08:46:51Z", "dateModified": "2015-12-16T08:46:51Z" } }, { "key": "QXXCPN6A", "version": 25, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/QXXCPN6A", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/QXXCPN6A", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/B2NKBZJ2", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "QXXCPN6A", "version": 25, "parentItem": "B2NKBZJ2", "itemType": "attachment", "linkMode": "imported_url", "title": "Aya Jakobovits, Ph.D., Named President and CEO of Kite Pharma, Inc. (NASDAQ:KITE)", "accessDate": "2015-12-16T08:35:04Z", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852510", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releasedetail.html", "md5": "d056c638690768709186188e494c5c77", "mtime": 1450254905165, "tags": [], "relations": {}, "dateAdded": "2015-12-16T08:35:04Z", "dateModified": "2015-12-16T08:35:04Z" } }, { "key": "B2NKBZJ2", "version": 24, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/B2NKBZJ2", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/B2NKBZJ2", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "B2NKBZJ2", "version": 24, "itemType": "webpage", "title": "Aya Jakobovits, Ph.D., Named President and CEO of Kite Pharma, Inc. (NASDAQ:KITE)", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=852510", "accessDate": "2015-12-16T08:35:02Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-12-16T08:35:02Z", "dateModified": "2015-12-16T08:35:02Z" } }, { "key": "6QFUG8QQ", "version": 23, "library": { "type": "group", "id": 445832, "name": "Kite Pharma", "links": { "alternate": { "href": "https://www.zotero.org/groups/kite_pharma", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/445832/items/6QFUG8QQ", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/kite_pharma/items/6QFUG8QQ", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/445832/items/W3MT2H5W", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2040857, "username": "kmedin14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/kmedin14", "type": "text/html" } } } }, "data": { "key": "6QFUG8QQ", "version": 23, "parentItem": "W3MT2H5W", "itemType": "attachment", "linkMode": "imported_url", "title": "Kite Pharma Files Registration Statement for Proposed Initial Public Offering (NASDAQ:KITE)", "accessDate": "2015-12-16T07:09:11Z", "url": "http://amda-2v2xoy.client.shareholder.com/releasedetail.cfm?ReleaseID=852488", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releasedetail.html", "md5": "aca46577fb4d9771bcd2059735fbb6a1", "mtime": 1450249752354, "tags": [], "relations": {}, "dateAdded": "2015-12-16T07:09:11Z", "dateModified": "2015-12-16T07:09:11Z" } } ]